九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603456 九洲药业

已收盘 05-09 15:00:00

{"stockData":{"symbol":"603456","market":"SH","secType":"STK","nameCN":"九洲药业","latestPrice":13.83,"timestamp":1746774000000,"preClose":13.91,"halted":0,"volume":7519400,"delay":0,"changeRate":-0.0058,"floatShares":894999999,"shares":894999999,"eps":0.6921,"marketStatus":"已收盘","change":-0.08,"latestTime":"05-09 15:00:00","open":13.93,"high":13.93,"low":13.79,"amount":104000000,"amplitude":0.0101,"askPrice":13.84,"askSize":145,"bidPrice":13.83,"bidSize":1240,"shortable":0,"etf":0,"ttmEps":0.6921,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.91,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":15.3,"lowLimit":12.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":895235828,"isCdr":false,"pbRate":1.41,"roa":"--","peRate":19.982661,"roe":"2.89%","epsLYR":0.68,"committee":-0.101592,"marketValue":12381000000,"turnoverRate":0.0084,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-05-12。","floatMarketCap":12381000000},"requestUrl":"/m/hq/s/603456","defaultTab":"news","newsList":[{"id":"2533979461","title":"九洲药业05月08日主力净流入875.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533979461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533979461?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:20","pubTimestamp":1746688815,"startTime":"0","endTime":"0","summary":"05月08日, 九洲药业股价涨1.16%，报收13.91元，成交金额1.5亿元，换手率1.21%，振幅1.67%，量比0.85。九洲药业今日主力资金净流入875.3万元，上一交易日主力净流出1819.8万元。该股近5个交易日上涨0.36%，主力资金累计净流出3437.0万元；近20日主力资金累计净流入154.6万元，其中净流入天数为7日。|05月08日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST双成|8.61%|#|跨境通|7.99%|#|中百集团|7.29%|#|...|...|#1271|九洲药业|0.07%|九洲药业所在的医疗服务行业，今日主力净流出4968万元，行业排名52/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508170247a4766f14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508170247a4766f14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2533677271","title":"九洲药业05月07日遭主力抛售1819.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533677271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533677271?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:19","pubTimestamp":1746602378,"startTime":"0","endTime":"0","summary":"05月07日, 九洲药业股价跌1.22%，报收13.75元，成交金额2.0亿元，换手率1.58%，振幅3.38%，量比1.13。九洲药业今日主力资金净流出1819.8万元，上一交易日主力净流出97.7万元。|05月07日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST精伦|9.01%|#|长华化学|6.32%|#|*ST国华|6.24%|#|...|...|#3819|九洲药业|-0.15%|九洲药业所在的医疗服务行业，今日主力净流出5.32亿元，行业排名26/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507162636a4751224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507162636a4751224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2531074037","title":"九洲药业04月30日遭主力抛售2328.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531074037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531074037?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:21","pubTimestamp":1745997675,"startTime":"0","endTime":"0","summary":"04月30日, 九洲药业股价跌1.58%，报收13.70元，成交金额1.7亿元，换手率1.35%，振幅2.23%，量比0.84。九洲药业今日主力资金净流出2328.0万元，连续7日净流出，上一交易日主力净流出66.9万元。该股近5个交易日下跌0.87%，主力资金累计净流出3517.3万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出8612.3万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164448a46d6b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164448a46d6b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0070","603456"],"gpt_icon":0},{"id":"2530236320","title":"社保基金大举扫货 一季度增持72只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530236320","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530236320?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:52","pubTimestamp":1745848366,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，上述324家公司累计获社保基金重仓持股54.97亿股，对应持股市值为853.85亿元。其中，宝钢股份获全国社保基金一一四组合新进买入1.58亿股，对应持仓市值为11.4亿元，占流通股比例为0.73%，暂时位列新进个股持有市值首位。增持72只个股增持方面，今年一季度社保基金加仓了中国巨石、鱼跃医疗、亿联网络、广联达、山金国际、国药股份、天山铝业等72只个股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821413697489104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821413697489104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603979","BK0188","399300","600803","600750","BK0028","601918","600310","601677","BK0196","600529","600176","603351","601128","600970","605183","688087","688122","BK0010","BK0082","600426","603067","BK0235","600389","603848","600285","BK0175","600452","159982","BK0187","605196","600511","603456","600256","603889","600988","600060","BK0164"],"gpt_icon":0},{"id":"2530825402","title":"九洲药业04月28日遭主力抛售9.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530825402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530825402?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:27","pubTimestamp":1745839667,"startTime":"0","endTime":"0","summary":"04月28日, 九洲药业股价跌0.07%，报收13.86元，成交金额1.7亿元，换手率1.40%，振幅1.80%，量比0.66。九洲药业今日主力资金净流出9.0万元，连续5日净流出，上一交易日主力净流出621.0万元。|04月28日主力加仓幅度排名||#|股票简称|主力净额占比|#|普利退|11.44%|#|胜通能源|9.94%|#|瀛通通讯|5.36%|#|...|...|#1937|九洲药业|-0.00%|九洲药业所在的医疗服务行业，今日主力净流出7283万元，行业排名88/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428203651a46a7b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428203651a46a7b28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2530710905","title":"九洲药业04月25日遭主力抛售621万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530710905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530710905?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:22","pubTimestamp":1745565772,"startTime":"0","endTime":"0","summary":"04月25日, 九洲药业股价跌0.36%，报收13.87元，成交金额1.83亿元，换手率1.47%，振幅1.87%，量比0.65。九洲药业今日主力资金净流出621万元，连续4日净流出，上一交易日主力净流出493万元。该股近5个交易日上涨3.74%，主力资金累计净流出3962万元；近20日主力资金累计净流出1.09亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164449a6c7c764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164449a6c7c764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2529062935","title":"九洲药业：富马酸伏诺拉生收到化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2529062935","media":"格隆汇资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529062935?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:32","pubTimestamp":1745479971,"startTime":"0","endTime":"0","summary":"格隆汇4月24日丨九洲药业(603456.SH)公布，全资子公司浙江九洲药物科技有限公司收到国家药品监督管理局颁发的关于富马酸伏诺拉生的《化学原料药上市申请批准通知书》。富马酸伏诺拉生主要用于治疗胃酸相关性疾病，包括反流性食管炎(RE)、胃溃疡、十二指肠溃疡等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042415330394e0a633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042415330394e0a633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2529278587","title":"九洲药业控股子公司获得拉考沙胺片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2529278587","media":"港美通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529278587?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:36","pubTimestamp":1745332617,"startTime":"0","endTime":"0","summary":"浙江九洲药业股份有限公司4月22日收盘后发布公告称，其控股子公司浙江九洲生物医药有限公司收到国家药品监督管理局核准签发的拉考沙胺片的《药品注册证书》。此次九洲生物获得的药品注册证书批准文号分别为国药准字H20253869和国药准字H20253870，有效期至2030年4月14日。公司表示，获得该药品注册证书将进一步丰富公司的产品管线，有助于提升公司产品的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042222381794de4461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042222381794de4461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","603456"],"gpt_icon":0},{"id":"2529879954","title":"九洲药业股价上涨2.24% CDMO项目稳健增长支撑市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879954","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529879954?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:27","pubTimestamp":1745231263,"startTime":"0","endTime":"0","summary":"截至2025年4月21日收盘，九洲药业股价报收13.67元，较前一交易日上涨2.24%。当日开盘后股价震荡上行，最高触及13.93元，最低回探13.21元，全天成交量为24.16万手，成交金额达3.30亿元，换手率为2.70%。公司近期在投资者互动平台表示，2025年一季度CDMO项目数量保持稳健增长，其中处于新药上市申请阶段的项目增速较快，为后续商业化生产奠定基础。此外，公司积极参与国际行业展会，包括DCAT Week、CPHI Japan等，持续强化全球业务合作与市场拓展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/21182749718882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CDMO","BK0070","BK0239","BK4139","603456"],"gpt_icon":0},{"id":"2529824878","title":"九洲药业：2025年一季度CDMO项目数保持稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2529824878","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529824878?lang=zh_cn&edition=full","pubTime":"2025-04-21 16:51","pubTimestamp":1745225495,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业04月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，贵公司3,4月份参加了很多国际展会，能介绍一下有什么阶段性的成果？或者有签署了什么协议吗？3月份有国际GMP会议、NextGenBiomed2025、BIO-Europe、DCATWeek等，4月份的in-cosmeticsGlobal、CPHIJapan国际制药原料日本展等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042100021575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2529682944","title":"九洲药业04月21日获主力加仓854万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682944","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682944?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:19","pubTimestamp":1745219993,"startTime":"0","endTime":"0","summary":"04月21日, 九洲药业股价涨2.24%，报收13.67元，成交金额3.30亿元，换手率2.70%，振幅5.39%，量比0.72。九洲药业今日主力资金净流入854万元，上一交易日主力净流入551万元。该股近5个交易日上涨7.22%，主力资金累计净流入8775万元；近20日主力资金累计净流出2286万元，其中净流出天数为11日。|04月21日主力加仓幅度排名||#|股票简称|主力净额占比|#|青岛金王|9.86%|#|阳光乳业|9.01%|#|新金路|6.41%|#|...|...|#1346|九洲药业|0.07%|九洲药业所在的医疗服务行业，今日主力净流入1.14亿元，行业排名38/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155612a460a8be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155612a460a8be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2528030374","title":"九洲药业04月18日主力净流入551万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528030374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528030374?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:21","pubTimestamp":1744960872,"startTime":"0","endTime":"0","summary":"04月18日, 九洲药业股价涨0.30%，报收13.37元，成交金额2.64亿元，换手率2.20%，振幅2.18%，量比0.57。九洲药业今日主力资金净流入551万元，上一交易日主力净流出1111万元。该股近5个交易日上涨6.53%，主力资金累计净流入8250万元；近20日主力资金累计净流出3794万元，其中净流出天数为12日。|04月18日主力加仓幅度排名||#|股票简称|主力净额占比|#|亚联机械|6.61%|#|永杰新材|6.36%|#|三夫户外|6.18%|#|...|...|#1229|九洲药业|0.05%|九洲药业所在的医疗服务行业，今日主力净流入5226万元，行业排名24/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418162636a6bf1039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418162636a6bf1039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0070","603456"],"gpt_icon":0},{"id":"2527926263","title":"九洲药业04月16日主力净流出5500万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527926263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527926263?lang=zh_cn&edition=full","pubTime":"2025-04-16 15:21","pubTimestamp":1744788089,"startTime":"0","endTime":"0","summary":"04月16日, 九洲药业股价跌4.78%，报收13.36元，成交金额6.94亿元，换手率5.70%，振幅5.06%，量比1.67。九洲药业今日主力资金净流出5500万元，上一交易日主力净流入1.40亿元。该股近5个交易日上涨6.28%，主力资金累计净流入1.04亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4738万元，其中净流出天数为12日。净流出前三个股分别为药明康德、九洲药业、贝瑞基因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416165805a45adc5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416165805a45adc5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2527280779","title":"九洲药业大跌5% 近半年5家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2527280779","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527280779?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:25","pubTimestamp":1744773935,"startTime":"0","endTime":"0","summary":"04月16日，九洲药业股价大幅下跌，截至11点25分，九洲药业下跌5.06%，报13.32元/股，成交4.57亿元，换手率3.73%，振幅4.78%。资金动向截止发稿，九洲药业获得主力净流出4188万元，其中超大单流出3212万元，大单流出975万元。此外，九洲药业04月15日上榜龙虎榜。最新财报显示，今年一季报，九洲药业实现营业收入14.90亿元，同比增长0.98%，净利润为2.50亿元，同比增长5.68%，基本每股收益为0.28元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416112553a6bc0712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416112553a6bc0712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2527002448","title":"九洲药业2025年第一季度净利润同比增长5.68% CDMO业务稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2527002448","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527002448?lang=zh_cn&edition=full","pubTime":"2025-04-15 20:40","pubTimestamp":1744720800,"startTime":"0","endTime":"0","summary":"九洲药业的业绩增长主要得益于其CDMO业务的稳步增长。九洲药业是一家技术驱动的CDMO企业，专注于为全球制药公司、生物科技公司、科研机构等提供一站式医药定制研发和生产服务，涵盖小分子化学药物、多肽药物、偶联药物和小核酸药物等领域。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-15/doc-inethcvq7683891.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-04-15/doc-inethcvq7683891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CDMO","603456"],"gpt_icon":0},{"id":"2527467900","title":"九洲药业：截至2025年4月7日已累计回购股份305.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527467900","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527467900?lang=zh_cn&edition=full","pubTime":"2025-04-15 17:49","pubTimestamp":1744710552,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业04月15日在投资者关系平台上答复投资者关心的问题。如果真想给予广大投资者信心，在4月7日股价跌停就应该阻击，大力度回购，而不是任由4月8日，9日继续大跌！九洲药业回复：您好，感谢您对公司的关注与支持，公司已发布2025年度回购股份计划，截至2025年4月7日，公司通过集中竞价交易方式已累计回购股份305.87万股，已支付的总金额为4061.62万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041500029580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2527046816","title":"九洲药业04月15日获主力大幅加仓1.40亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527046816","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527046816?lang=zh_cn&edition=full","pubTime":"2025-04-15 15:21","pubTimestamp":1744701662,"startTime":"0","endTime":"0","summary":"04月15日, 九洲药业股价涨10.04%，报收14.03元，成交金额8.25亿元，换手率6.62%，振幅4.86%，量比2.37。九洲药业今日主力资金净流入1.40亿元，连续3日净流入，上一交易日主力净流入328万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为2.62%。该股近5个交易日上涨9.78%，主力资金累计净流入1.60亿元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入2799万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415162654a4596f9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415162654a4596f9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0070","603456"],"gpt_icon":0},{"id":"2526248640","title":"九洲药业2024年业绩下滑，应收账款高企，需关注经营风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2526248640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526248640?lang=zh_cn&edition=full","pubTime":"2025-04-12 06:14","pubTimestamp":1744409647,"startTime":"0","endTime":"0","summary":"主要财务指标分析毛利率与净利率2024年，九洲药业的毛利率为33.78%，同比下降10.29%；净利率为11.76%，同比下降37.0%。同时，应收账款为11.95亿元，同比增长24.23%，且应收账款占归母净利润的比例高达197.24%，显示出较大的资金回收压力。主营业务构成九洲药业的主要收入来源为合同定制类产品，收入为38.71亿元，占主营收入的75.00%，毛利率为38.38%。风险提示九洲药业在2024年面临较大的经营压力，尤其是应收账款的高企和净利润的大幅下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412061612a6b83b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412061612a6b83b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603456","BK0070","BK0239"],"gpt_icon":0},{"id":"2518905887","title":"九洲药业03月11日遭主力抛售129万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518905887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518905887?lang=zh_cn&edition=full","pubTime":"2025-03-11 15:20","pubTimestamp":1741677625,"startTime":"0","endTime":"0","summary":"03月11日, 九洲药业股价跌1.16%，报收13.63元，成交金额1.65亿元，换手率1.36%，振幅1.09%，量比1.04。九洲药业今日主力资金净流出129万元，连续5日净流出，上一交易日主力净流出1334万元。该股近5个交易日下跌2.78%，主力资金累计净流出4700万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1.42亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311161106a1d484b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311161106a1d484b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603456","BK0070"],"gpt_icon":0},{"id":"2518214726","title":"九洲药业：股价波动受多种因素影响，公司生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2518214726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518214726?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:15","pubTimestamp":1741598145,"startTime":"0","endTime":"0","summary":"证券之星消息，九洲药业(603456)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，大盘都要攻3400点了，公司股价还在2700点，公司股价不给力，只会让人更加坚信有潜在风险哦。赶快拿出实力证明公司经营一切正常吧。九洲药业回复：您好，感谢您对公司的关注与支持，股价波动受多种因素影响，公司生产经营正常，谢谢！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000023095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","603456"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746918701422,"stockEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.1002},{"period":"3month","weight":0.0237},{"period":"6month","weight":-0.1577},{"period":"1year","weight":-0.1348},{"period":"ytd","weight":0.011}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江九洲药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"53978人(较上一季度增加1.31%)","perCapita":"16585股","listingDate":"2014-10-10","address":"浙江省台州市椒江区外沙路99号","registeredCapital":"89523万元","survey":"　　浙江九洲药业股份有限公司的主营业务是为全球制药公司、生物科技公司、科研机构等提供一站式的医药定制研发和生产（CDMO）服务，包含小分子化学药物、多肽药物、偶联药物和小核酸药物。公司的主要产品是合同定制类、抗感染类、中枢神经类药物、非甾体类药物、降血糖类药。报告期内，公司荣获2024中国医药CDMO企业20强、2023年度中国医药工业百强系列榜单-2023年度中国CXO企业TOP20、浙江省生物医药产业领军型企业等多项荣誉。","listedPrice":15.43},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九洲药业,603456,九洲药业股票,九洲药业股票老虎,九洲药业股票老虎国际,九洲药业行情,九洲药业股票行情,九洲药业股价,九洲药业股市,九洲药业股票价格,九洲药业股票交易,九洲药业股票购买,九洲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九洲药业(603456)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九洲药业(603456)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}